AKAP 3 (A-kinase anchoring protein 3) inhibitors are a class of small molecules that specifically target and modulate the activity of AKAP 3, a protein known for its crucial role in cellular signaling pathways. AKAP 3 is a member of the A-kinase anchoring protein (AKAP) family, which plays a pivotal role in compartmentalizing and regulating the activity of protein kinase A (PKA) and other signaling molecules within cells. These proteins act as scaffolds, facilitating the precise localization and coordination of intracellular signaling events. AKAP 3, in particular, is predominantly found in the mitochondria of cells and has been implicated in various cellular processes, including mitochondrial function, cell cycle regulation, and cell survival.
AKAP 3 inhibitors are designed to disrupt the interaction between AKAP 3 and its binding partners, particularly PKA. By interfering with this interaction, these inhibitors have the potential to modulate downstream signaling pathways and influence cellular responses. These compounds are valuable tools for researchers studying the intricate mechanisms of intracellular signaling and can aid in understanding the role of AKAP 3 in various physiological and pathological processes. While the development and study of AKAP 3 inhibitors are ongoing, their potential applications extend beyond their role as research tools, offering the promise of future insights into the fundamental processes that govern cellular function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rp-cAMPS | 151837-09-1 | sc-24010 | 1 mg | $203.00 | 37 | |
A cAMP analog that antagonizes cAMP-dependent PKA activation, indirectly affecting AKAP3's role in PKA anchoring. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $138.00 $220.00 $972.00 | 47 | |
This compound selectively inhibits PKA, thereby possibly altering the signaling pathways associated with AKAP3. | ||||||
PKI (14-22) amide (myristoylated) | 201422-03-9 | sc-471154 | 0.5 mg | $135.00 | 2 | |
A synthetic peptide that inhibits PKA, which is a key enzyme in the signaling pathways where AKAP3 is involved. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
By modulating cyclic AMP levels, adenosine can indirectly influence the PKA pathways associated with AKAP3. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Though a known inhibitor of protein kinase C (PKC), it might have off-target effects on PKA pathways and consequently on AKAP3. | ||||||
KT5823 | 126643-37-6 | sc-3534 sc-3534A sc-3534B | 100 µg 1 mg 5 mg | $182.00 $1228.00 $4895.00 | 21 | |
Primarily a PKG inhibitor, but as signaling pathways often have cross-talk, it could indirectly influence AKAP3's role. | ||||||
HA-1004 Dihydrochloride | 91742-10-8 | sc-200537 sc-200537A | 10 mg 25 mg | $88.00 $270.00 | 1 | |
A kinase inhibitor with potential effects on PKA, thereby affecting the AKAP3 anchored signaling pathways. | ||||||